[ad_1] Hello! This week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in…
Browsing: AMGN
[ad_1] The keepers of the Dow Jones Industrial Average have been very good at making sure the changes they make…
[ad_1] Amgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as revenues dropped for one of…
[ad_1] Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple…
[ad_1] Amgen Inc.’s stock fell 3.3% Tuesday to put it on track for its biggest one-day percentage decline in more…
[ad_1] Mohammed Haneefa Nizamudeen As the FDA continues to mull the fate of Amgen’s lung cancer drug Lumakras, Sanofi is…
[ad_1] The Rule of 40 is a shorthand way for venture-capital investors to evaluate companies. These investors are looking for…
[ad_1] Shares of Horizon Therapeutics PLC plunged 15% in extended trading Monday after Bloomberg News reported the FTC is expected…
[ad_1] Amgen Inc. on Thursday said it would lay off about 450 employees, or less than 2% of its workforce,…
[ad_1] Financial conditions might be tighter this year as the Federal Reserve keeps up its inflation fight, but they have…